Kyverna Therapeutics (KYTX) Non-Current Debt (2025 - 2026)

Kyverna Therapeutics (KYTX) has 2 years of Non-Current Debt data on file, last reported at $24.8 million in Q1 2026.

• Quarterly Non-Current Debt changed N/A year-over-year to $24.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.8 million (changed N/A YoY) and the FY2025 annual result came in at $24.7 million, changed N/A from the prior year.
• Non-Current Debt steadied at $24.8 million in Q1 2026, from $24.7 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $24.8 million in Q1 2026 to a low of $24.7 million in Q4 2025.